You are here

  • Home
  • Archive
  • Volume 70, Issue 12
  • RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease

Article info

Article menu
Hepatology
Original research
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease

Authors

  • Marta B Afonso Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal PubMed articlesGoogle scholar articles
  • Pedro M Rodrigues Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal PubMed articlesGoogle scholar articles
  • Miguel Mateus-Pinheiro Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal PubMed articlesGoogle scholar articles
  • André L Simão Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal PubMed articlesGoogle scholar articles
  • Maria M Gaspar Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal PubMed articlesGoogle scholar articles
  • Amine Majdi Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France Institute of Cardiometabolism and Nutrition (ICAN), Paris, France PubMed articlesGoogle scholar articles
  • Enara Arretxe OWL Metabolomics, Bizkaia Technology Park, Derio, Spain PubMed articlesGoogle scholar articles
  • Cristina Alonso OWL Metabolomics, Bizkaia Technology Park, Derio, Spain PubMed articlesGoogle scholar articles
  • Alvaro Santos-Laso Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain PubMed articlesGoogle scholar articles
  • Raul Jimenez-Agüero Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain PubMed articlesGoogle scholar articles
  • Emma Eizaguirre Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain PubMed articlesGoogle scholar articles
  • Luis Bujanda Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain PubMed articlesGoogle scholar articles
  • Maria Jesus Pareja Hospital Universitario de Valme, Sevilla, Andalucía, Spain PubMed articlesGoogle scholar articles
  • Jesus M Banales Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain PubMed articlesGoogle scholar articles
  • Vlad Ratziu Institute of Cardiometabolism and Nutrition (ICAN), Paris, France Department of Hepatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, Paris, France Sorbonne Université, Inserm, Centre de Recherche des Cordeliers (CRC), Paris, France PubMed articlesGoogle scholar articles
  • Jeremie Gautheron Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine (CRSA), Paris, France Institute of Cardiometabolism and Nutrition (ICAN), Paris, France PubMed articlesGoogle scholar articles
  • Rui E Castro Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal PubMed articlesGoogle scholar articles
  • Cecília M P Rodrigues Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Cecília M P Rodrigues, Faculty of Pharmacy, Universidade de Lisboa, Lisboa 1649-003, Portugal; cmprodrigues{at}ff.ul.pt
View Full Text

Citation

Afonso MB, Rodrigues PM, Mateus-Pinheiro M, et al
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
Gut 2021;70:2359-2372.

Publication history

  • Received May 9, 2020
  • Revised September 22, 2020
  • Accepted November 25, 2020
  • First published December 24, 2020.
Online issue publication 
January 08, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.